L
Luc Rochette
Researcher at University of Burgundy
Publications - 349
Citations - 10029
Luc Rochette is an academic researcher from University of Burgundy. The author has contributed to research in topics: Oxidative stress & Ischemia. The author has an hindex of 49, co-authored 326 publications receiving 8672 citations. Previous affiliations of Luc Rochette include French Institute of Health and Medical Research & University of Strathclyde.
Papers
More filters
Journal ArticleDOI
Diabetes, oxidative stress and therapeutic strategies
TL;DR: It appears important to develop new compounds that target key vascular ROS producing enzymes and mimic endogenous antioxidants, which might prove clinically relevant in preventing the development and/or retarding the progression of diabetes associated with vascular diseases.
Journal ArticleDOI
Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Luc Rochette,Julie Lorin,Marianne Zeller,Jean-Claude Guilland,Luc Lorgis,Yves Cottin,Catherine Vergely +6 more
TL;DR: It appears that both a lack and excess of NO production in diseases can have various important pathological implications, and NOS modulators (exogenous and endogenous) and their therapeutic effects are discussed.
Journal ArticleDOI
Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs).
TL;DR: This review analyzed the therapeutic advancement of ADSCs in comparison to bone marrow (BM) and umbilical cord (UC)-mesenchymal stem cells (MSCs) and designed the specific requirements to their best clinical practices and safety.
Journal ArticleDOI
Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential
TL;DR: Dietary supplementation with α-lipoic acid has been successfully employed in a variety of in vivo models of disease associated with an imbalance of redox status: diabetes and cardiovascular diseases.
Journal ArticleDOI
Hopes and Limits of Adipose-Derived Stem Cells (ADSCs) and Mesenchymal Stem Cells (MSCs) in Wound Healing.
TL;DR: ADSCs fulfill the general accepted criteria for cell-based therapies, but still need further investigations into their efficiency, taking into consideration the host-environment and patient-associated factors.